Stock Quote



Price $ 0.33

Change +0.00 (+0%)

Volume 254,900

Day High $ 0.35

Day Low $ 0.32

52 Week High $ 2.99


52 Week Low $ 0.21

Today's Open $ 0.35

Previous Close $ 0.33

May 25, 2017 05:00 PM Pricing delayed 20 minutes

Financials & Filings

View All


April 12, 2017 CEO Message to Shareholders (from 2016 Annual Report)
DearShareholders, It’s remarkable the difference one year can make. I’d like to tell you how we felt upon learning of the negative KIACTATM Phase 3 AA amyloidosis results in mid 2016, how we decided to rebuild from this bitter disappointment and why we are more excited than ever about the future-particularly because of our new project, BLU-5937. Shocked and disappointed. From our partners at...
Read More
April 8, 2016 CEO Message to Shareholders (from 2015 Annual Report)
Dear Shareholders, We have made important progress in our business plan in 2015 that has setup the coming year to be one of the most important in our Company history. Developing Rare Disease Drugs is a Growing Trend Regulatory agencies, and particularly the US Food and Drug Administration (FDA), are increasingly approving innovative drugs and in particular drugs that treat rare diseases. Last...
Read More

Share this

Sign up for email alerts

Email Address *
Enter the code shown above.